121 related articles for article (PubMed ID: 10560994)
1. Effects of tibolone on auditory brainstem responses in postmenopausal women--a randomized, double-blind, placebo-controlled trial.
Sator MO; Franz P; Egarter C; Gruber DM; Wölfl G; Nagele F
Fertil Steril; 1999 Nov; 72(5):885-8. PubMed ID: 10560994
[TBL] [Abstract][Full Text] [Related]
2. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
Laan E; van Lunsen RH; Everaerd W
Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures.
Pavlov PW; Ginsburg J; Kicovic PM; van der Schaaf DB; Prelevic G; Bennink HJ
Gynecol Endocrinol; 1999 Aug; 13(4):230-7. PubMed ID: 10533157
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the effectiveness of postmenopausal tibolone therapy on neural functions by measuring visual evoked potentials: a placebo-controlled study.
Laçin S; Oruç S; Karaca S; Kusçu K; Koyuncu F; Uyar Y; Caglar H
Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):72-6. PubMed ID: 11516803
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
Hammar M; Christau S; Nathorst-Böös J; Rud T; Garre K
Br J Obstet Gynaecol; 1998 Aug; 105(8):904-11. PubMed ID: 9746385
[TBL] [Abstract][Full Text] [Related]
6. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.
Taskin O; Yalcinoglu AI; Kucuk S; Uryan I; Buhur A; Burak F
Fertil Steril; 1997 Jan; 67(1):40-5. PubMed ID: 8986681
[TBL] [Abstract][Full Text] [Related]
8. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
Di Carlo C; Palomba S; Tommaselli GA; Guida M; Di Spiezio Sardo A; Nappi C
Fertil Steril; 2001 Feb; 75(2):380-4. PubMed ID: 11172843
[TBL] [Abstract][Full Text] [Related]
9. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial.
Kubista E; Planellas Gomez JV; Dowsett M; Foidart JM; Pohlodek K; Serreyn R; Nechushkin M; Manikhas AG; Semiglazov VF; Hageluken CC; Singer CF
Clin Cancer Res; 2007 Jul; 13(14):4185-90. PubMed ID: 17634547
[TBL] [Abstract][Full Text] [Related]
10. Tibolone: prevention of bone loss in late postmenopausal women.
Bjarnason NH; Bjarnason K; Haarbo J; Rosenquist C; Christiansen C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2419-22. PubMed ID: 8675554
[TBL] [Abstract][Full Text] [Related]
11. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women.
Cicinelli E; Ignarro LJ; Galantino P; Pinto V; Barba B; Schonauer S
Fertil Steril; 2002 Sep; 78(3):464-8. PubMed ID: 12215318
[TBL] [Abstract][Full Text] [Related]
12. Short-term tibolone does not interfere with endothelial function: a double-blinded, randomized, controlled trial.
Celani MF; Hurtado R; Brandão AH; Maciel da Fonseca AM; Geber S
Climacteric; 2016 Jun; 19(3):299-302. PubMed ID: 27031181
[TBL] [Abstract][Full Text] [Related]
13. The influence of tibolone on quality of life in postmenopausal women.
Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
Maturitas; 2002 Jan; 41(1):35-43. PubMed ID: 11809341
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
15. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study.
Berning B; Kuijk CV; Kuiper JW; Bennink HJ; Kicovic PM; Fauser BC
Bone; 1996 Oct; 19(4):395-9. PubMed ID: 8894146
[TBL] [Abstract][Full Text] [Related]
16. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
Kroiss R; Fentiman IS; Helmond FA; Rymer J; Foidart JM; Bundred N; Mol-Arts M; Kubista E
BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
[TBL] [Abstract][Full Text] [Related]
17. The influence of tibolone upon serum leptin levels in post-menopausal women.
Panidis DK; Rousso DH; Kourtis AI; Stergiopoulos KN; Mavromatidis GA; Katsikis IK
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):85-7. PubMed ID: 11311767
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study.
Taskin O; Muderrisoglu H; Akar M; Simsek M; Mendilcioglu I; Kursun S
Maturitas; 2004 Aug; 48(4):354-9. PubMed ID: 15283927
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled, crossover study of tibolone (Livial) on menopause symptoms, psychological well-being, and dyadic relationship of postmenopausal Chinese women and their spouses.
Lam PM; Cheung GW; Shek DT; Lee DT; Haines CJ; Chung TK
Menopause; 2004; 11(4):416-22. PubMed ID: 15243279
[TBL] [Abstract][Full Text] [Related]
20. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
